Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

University of Oxford Skyline

The highly competitive Cancer Research UK Centre awards recognise the UK’s most innovative, high-impact cancer research and NHS-University collaborations. This coveted funding, announced today, will see £11 million invested in Oxford and the Thames Valley’s cancer research and translational infrastructure, and a further £3 million into training over the next 5 years.

Cancer remains the second largest cause of global mortality, impacting the lives of millions worldwide. Half of us will be diagnosed with cancer, and there is a strong demand for investment in academic excellence, and to support partnerships with industry and public health organisations.

Within Oxford, the funding will draw together academics and experts from across its fundamental, translational and clinical research communities including from cancer doctors, mathematicians, computer & data scientists, vaccinologists, immunologists, cellular biologists, drug discovery experts, clinical trialists, imaging experts and public health specialists. Nationally and internationally, the new investment will foster a multisectoral approach and invest partnerships that will deliver short and long term patient benefit.

Read the full story on the Oxford Cancer website. 

Similar stories

Anant Parekh to deliver The Physiological Society's Annual Review Prize Lecture

The Annual Review Prize Lecture is The Physiological Society's most prestigious lecture.

Professor Sir Andrew Pollard Awarded the James Spence Medal in 2022

Professor Sir Andrew Pollard, BSc MA MBBS MRCP(UK) FRCPCH PhD DIC FHEA FIDSA FMedSci, is Professor of Paediatric Infection and Immunity at the University of Oxford, Honorary Consultant Paediatrician at Oxford Children’s Hospital and Vice Master of St Cross College, Oxford.

Department of Paediatrics celebrates 50-year anniversary

After being established in 1972, the Department of Paediatrics' contributions have spanned teaching, innovation, and research. The department also builds upon a longer lineage in Oxford that has impacted child health.

COVID-19 vaccine protects people of all body weights from hospitalisation and death, a study of 9 million adults in England finds

Two doses of the COVID-19 vaccine are effective against severe disease for people who are underweight, overweight, or who have obesity, finds new research published in The Lancet Diabetes and Endocrinology, led by researchers at the University of Oxford.

PhD Student of the Year 2022 Winner!

Congratulations to Nuffield Department of Women's & Reproductive Health DPhil student Josephine Agyeman-Duah on being named winner of PhD Student of the Year at the Postgrad Awards 2022.